ArticleThe Journal of infectious diseases2011

IL28B but not ITPA polymorphism is predictive of response to pegylated interferon, ribavirin, and telaprevir triple therapy in patients with genotype 1 hepatitis C.

Kazuaki Chayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.